NCT/Study#

SY-2101-101

An Open-label Phase 1 Study to Evaluate Pharmacokinetics, Safety, and Tolerability of SY-2101 in Adult Patients with Acute Promyelocytic Leukemia

An Open-label Phase 1 Study to Evaluate Pharmacokinetics, Safety, and Tolerability of SY-2101
in Adult Patients with Acute Promyelocytic Leukemia

DISEASE GROUP:
Leukemia
current phase:
Phase I
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: